抗利福平结核分枝杆菌的多药耐药性调查  

AN INVESTIGATION ON MULTIPLE DRUG RESISTANCE OF THE RIFAMPIN RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS

作　　者：匡铁吉[1] 金关甫[1] 宋萍[1] 李伟霞[1] 王仲元[1] 

机构地区：[1]解放军三0九医院,北京100091

出　　处：《微生物学报》1998年第2期152-154,共3页Acta Microbiologica Sinica

摘　　要：The correlation between rifampin resistance and multiple drug resistance in 236 clinical isolates of Mycobacterium tuberculosis was investigated in this thesis. It has found that 99.4% of the strains with rifampin resistance were multidrug-resistant strains and 89% of the multidrug-resistant strains were resistant to rifampin. This result showed that the rifampin resistance of Tuberculosis baccilli could be used as the marker of multidrug resistance of Mycobacterium tuberculosis.The correlation between rifampin resistance and multiple drug resistance in 236 clinical isolates of Mycobacterium tuberculosis was investigated in this thesis. It has found that 99.4% of the strains with rifampin resistance were multidrug-resistant strains and 89% of the multidrug-resistant strains were resistant to rifampin. This result showed that the rifampin resistance of Tuberculosis baccilli could be used as the marker of multidrug resistance of Mycobacterium tuberculosis.

关 键 词：结核分枝杆菌 利福平 多药耐药性 

分 类 号：R378.911[医药卫生—病原生物学] R978.3[医药卫生—基础医学]